Detection of Single Cancer Cell Multidrug Resistance With Single Cell Bioanalyzer

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2023 Jul 10

PMID 37424497

Authors

Jun Cai

Xing-Xing Fan

Run-Ze Li

Hong Lin

Min Li

Qi Song

Chun Xie

Gregory Wong

Sam Ting-Chung Liu

Ya-Bing Cao

Elaine Lai-Han Leung

Affiliations

Soon will be listed here.

Abstract

Despite the development of various cancer treatment methods, chemotherapy remains the most common approach for treating cancer. The risk of tumors acquiring resistance to chemotherapy remains a significant hurdle to the successful treatment of various types of cancer. Therefore, overcoming or predicting multidrug resistance in clinical treatment is essential. The detection of circulating tumor cells (CTCs) is an important component of liquid biopsy and the diagnosis of cancer. This study aims to test the feasibility of single-cell bioanalyzer (SCB) and microfluidic chip technology in identifying patients with cancer resistant to chemotherapy and propose new methods to provide clinicians with new choices. In this study, we used rapidly isolated viable CTCs from the patient blood samples method combined with SCB technology and a novel microfluidic chip, to predict whether patients with cancer are resistant to chemotherapy. SCB and microfluidic chip were used to select single CTCs, and the accumulation of chemotherapy drug was fluorescently measured in real time on these cells in the absence and presence of permeability-glycoprotein inhibitors. Initially, we successfully isolated viable CTCs from the blood samples of patients. Additionally, the present study accurately predicted the response of 4 lung cancer patients to chemotherapeutic drugs. In addition, the CTCs of 17 patients with breast cancer diagnosed at Zhuhai Hospital of Traditional Chinese and Western Medicine were assessed. The results indicated that 9 patients were sensitive to chemotherapeutic drugs, 8 patients were resistant to a certain degree, and only 1 was completely resistant to chemotherapy. The present study indicated that the SCB technology could be used as a prognostic assay to evaluate the CTCs response to available drugs and guide physicians to treatment options that are most likely to be effective.

References

Wang J, Seebacher N, Shi H, Kan Q, Duan Z . Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget. 2017; 8(48):84559-84571. PMC: 5663620. DOI: 10.18632/oncotarget.19187. View

Peng X, Li P . A three-dimensional flow control concept for single-cell experiments on a microchip. 1. Cell selection, cell retention, cell culture, cell balancing, and cell scanning. Anal Chem. 2004; 76(18):5273-81. DOI: 10.1021/ac049384s. View

Alix-Panabieres C, Pantel K . Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 2016; 6(5):479-91. DOI: 10.1158/2159-8290.CD-15-1483. View

Dallavalle S, Dobricic V, Lazzarato L, Gazzano E, Machuqueiro M, Pajeva I . Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist Updat. 2020; 50:100682. DOI: 10.1016/j.drup.2020.100682. View

Robertson E, Baxter G . Tumour seeding following percutaneous needle biopsy: the real story!. Clin Radiol. 2011; 66(11):1007-14. DOI: 10.1016/j.crad.2011.05.012. View

Wu Q, Yang Z, Nie Y, Shi Y, Fan D . Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014; 347(2):159-66. DOI: 10.1016/j.canlet.2014.03.013. View

Waghray D, Zhang Q . Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment. J Med Chem. 2017; 61(12):5108-5121. PMC: 6281405. DOI: 10.1021/acs.jmedchem.7b01457. View

Bukowski K, Kciuk M, Kontek R . Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020; 21(9). PMC: 7247559. DOI: 10.3390/ijms21093233. View

Li X, Chen Y, Li P . A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells. Lab Chip. 2011; 11(7):1378-84. DOI: 10.1039/c0lc00626b. View

10.

Shen F, Li X, Li P . Study of flow behaviors on single-cell manipulation and shear stress reduction in microfluidic chips using computational fluid dynamics simulations. Biomicrofluidics. 2014; 8(1):014109. PMC: 3977823. DOI: 10.1063/1.4866358. View

11.

Khamenehfar A, Wan C, Li P, Letchford K, Burt H . Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation. Anal Bioanal Chem. 2014; 406(28):7071-83. DOI: 10.1007/s00216-014-8151-7. View

12.

Vasseur A, Kiavue N, Bidard F, Pierga J, Cabel L . Clinical utility of circulating tumor cells: an update. Mol Oncol. 2020; 15(6):1647-1666. PMC: 8169442. DOI: 10.1002/1878-0261.12869. View

13.

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud J, Padovani B . "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One. 2014; 9(10):e111597. PMC: 4216113. DOI: 10.1371/journal.pone.0111597. View

14.

Pantel K, Speicher M . The biology of circulating tumor cells. Oncogene. 2015; 35(10):1216-24. DOI: 10.1038/onc.2015.192. View

15.

Li X, Huang J, Tibbits G, Li P . Real-time monitoring of intracellular calcium dynamic mobilization of a single cardiomyocyte in a microfluidic chip pertaining to drug discovery. Electrophoresis. 2007; 28(24):4723-33. DOI: 10.1002/elps.200700312. View

16.

Luqmani Y . Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2005; 14 Suppl 1:35-48. DOI: 10.1159/000086183. View

17.

De Rubis G, Rajeev Krishnan S, Bebawy M . Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis. Trends Pharmacol Sci. 2019; 40(3):172-186. DOI: 10.1016/j.tips.2019.01.006. View

18.

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

19.

Ferreira R, Dos Santos D, Ferreira M . P-glycoprotein and membrane roles in multidrug resistance. Future Med Chem. 2015; 7(7):929-46. DOI: 10.4155/fmc.15.36. View

20.

Yap K, Cohen E, Reuben J, Khoury J . Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications. Curr Hematol Malig Rep. 2019; 14(5):353-357. DOI: 10.1007/s11899-019-00531-x. View